Doxazosin Tablet
Product Images NDC 55154-7996

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 55154-7996). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (08521333 Ff21 45ad B99e 1f43d945d24d 00)

This is a medication label for Doxazosin Tablets USP, which contains 2mg of Doxazosin Mesylate per tablet. The usual dosage information, precautions, and warnings can be found in the product insert located at www.majorpharmaceuticals.com. The tablets should be stored at 20° to 25°C (68" 1o 77°F), with excursions permitted from 15° to 30°C (59° to | és “F) and should be kept out of reach of children. The medication is not child-resistant and is intended for oral use only. The label also includes manufacturing and distribution information.*

FDA Label Image

Doxazosin-structure (Doxazosin Structure)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Table3.jpg (Table3)

The text provides a summarized table of effectiveness data in placebo-controlled trials for doxazosin in treating benign prostatic hyperplasia. The table compares maximum flow rate, symptom score, and change in the effectiveness phase of different studies. The results are presented in means and changes from baseline. The AUA questionnaire and Modified Boyarsky Questionnaire were used to evaluate efficacy in different studies. The dosage and number of patients were also mentioned. There is no clear context or conclusion provided, making it difficult to interpret the findings.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.